Globex Current Cash and Share Position

(TSX:GMX),(Frankfurt:G1MN),(Stuttgart:G1MN),(Berlin:G1MN),(Munich:G1MN),(XETRA:G1MN),(OTC US:GLBXF),(Other OTC:GLBXF),(CNSX:ATMY.CN),(Frankfurt:K8JO), TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Dusseldorf and Quotrix Dusseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders that Emperor Metals Inc. […]

Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of Innovative Extracellular Vesicle Topical Formulations and Advanced Biologic Therapies

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) — Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced the appointment of Dr. Omar Khalid Sial, Ph.D. as its Chief Scientific Officer. Dr. Sial is a distinguished researcher whose work integrates neuroscience, immunology, and genetics. With

Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board

Appointment aligns Board leadership with Company's transition to clinical-stage development and advancement of KAD-101 for platinum-resistant ovarian cancer Company advancing KAD-101, a best-in-class, next-generation prolactin receptor antagonist, toward a Phase 1 clinical study FORT LAUDERDALE, FL, Jan. 22, 2026 (GLOBE NEWSWIRE) — Kaida BioPharma (“Kaida” or the “Company”), Kaida BioPharma (“Kaida” or the “Company”), a

Safe Bulkers, Inc. Announces Agreement for the Acquisition of Two Newbuild Kamsarmax Class Dry-bulk Vessels

(NYSE:SB),(NYSE:SB-PC),(NYSE:SB-PD), MONACO, Jan. 22, 2026 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it has entered into an agreement for the acquisition of two newbuild, 82,500 dwt, dry-bulk, Chinese, Kamsarmax class vessels, with scheduled delivery dates in the third quarter of 2028

Arqit Launches Encryption Intelligence: Automated Cryptographic Discovery for Post-Quantum Migration and Compliance

(NASDAQ:ARQQ),(NASDAQ:ARQQW), LONDON, Jan. 22, 2026 (GLOBE NEWSWIRE) — Arqit (Nasdaq: ARQQ, ARQQW), a global leader in quantum-safe encryption, today announced the full commercial launch of Encryption Intelligence (EI), a product that delivers a complete cryptographic inventory, alongside continuous discovery and risk prioritisation to help enterprises plan and execute migration to post-quantum cryptography (PQC) efficiently and

J-Star Files Formal Complaints Against PwC with AICPA and PCAOB

(NASDAQ:YMAT), TAICHUNG CITY, Taiwan, Jan. 22, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions serving diverse applications including personal sports equipment, healthcare products, automobile parts, resin systems, and research and development services, today announced that the Company has filed

Avalon GloboCare’s Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary

(NASDAQ:ALBT), FREEHOLD, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that its subsidiary, Avalon Quantum AI LLC, has filed a U.S. provisional patent application covering a new

TDb Split Corp. At-The-Market Equity Program Renewed

(TSX:XTD),(TSX:XTD.PR.A),(TSX:XTD-PA), TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) — TDb Split Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of the Company to the public from time to time at the Company's discretion, effective until February 21, 2028, unless terminated prior to such date

Financial 15 Split Corp. At-The-Market Equity Program Renewed

(TSX:FTN),(TSX:FTN.PR.A),(TSX:FTN-PA), TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of the Company to the public from time to time at the Company's discretion, effective until February 21, 2028 unless terminated prior to such

Dividend Select 15 Corp. At-The-Market Equity Program Renewed

(TSX:DS), TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) — Dividend Select 15 Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of the Company to the public from time to time at the Company's discretion, effective until February 21, 2028, unless terminated prior to such

Scroll to Top